Cargando…

Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab

Detalles Bibliográficos
Autores principales: Mikhailova, Ekaterina, Gluhanyuk, Evgeny, Illarionova, Olga, Zerkalenkova, Elena, Kashpor, Svetlana, Miakova, Natalia, Diakonova, Yulia, Olshanskaya, Yulia, Shelikhova, Larisa, Novichkova, Galina, Maschan, Michael, Maschan, Alexey, Popov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252946/
https://www.ncbi.nlm.nih.gov/pubmed/33375769
http://dx.doi.org/10.3324/haematol.2019.241596
_version_ 1783717404842393600
author Mikhailova, Ekaterina
Gluhanyuk, Evgeny
Illarionova, Olga
Zerkalenkova, Elena
Kashpor, Svetlana
Miakova, Natalia
Diakonova, Yulia
Olshanskaya, Yulia
Shelikhova, Larisa
Novichkova, Galina
Maschan, Michael
Maschan, Alexey
Popov, Alexander
author_facet Mikhailova, Ekaterina
Gluhanyuk, Evgeny
Illarionova, Olga
Zerkalenkova, Elena
Kashpor, Svetlana
Miakova, Natalia
Diakonova, Yulia
Olshanskaya, Yulia
Shelikhova, Larisa
Novichkova, Galina
Maschan, Michael
Maschan, Alexey
Popov, Alexander
author_sort Mikhailova, Ekaterina
collection PubMed
description
format Online
Article
Text
id pubmed-8252946
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-82529462021-07-14 Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab Mikhailova, Ekaterina Gluhanyuk, Evgeny Illarionova, Olga Zerkalenkova, Elena Kashpor, Svetlana Miakova, Natalia Diakonova, Yulia Olshanskaya, Yulia Shelikhova, Larisa Novichkova, Galina Maschan, Michael Maschan, Alexey Popov, Alexander Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-12-30 /pmc/articles/PMC8252946/ /pubmed/33375769 http://dx.doi.org/10.3324/haematol.2019.241596 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Mikhailova, Ekaterina
Gluhanyuk, Evgeny
Illarionova, Olga
Zerkalenkova, Elena
Kashpor, Svetlana
Miakova, Natalia
Diakonova, Yulia
Olshanskaya, Yulia
Shelikhova, Larisa
Novichkova, Galina
Maschan, Michael
Maschan, Alexey
Popov, Alexander
Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
title Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
title_full Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
title_fullStr Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
title_full_unstemmed Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
title_short Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
title_sort immunophenotypic changes of leukemic blasts in children with relapsed/refractory b-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252946/
https://www.ncbi.nlm.nih.gov/pubmed/33375769
http://dx.doi.org/10.3324/haematol.2019.241596
work_keys_str_mv AT mikhailovaekaterina immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT gluhanyukevgeny immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT illarionovaolga immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT zerkalenkovaelena immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT kashporsvetlana immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT miakovanatalia immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT diakonovayulia immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT olshanskayayulia immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT shelikhovalarisa immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT novichkovagalina immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT maschanmichael immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT maschanalexey immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab
AT popovalexander immunophenotypicchangesofleukemicblastsinchildrenwithrelapsedrefractorybcellprecursoracutelymphoblasticleukemiawhohavebeentreatedwithblinatumomab